🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Presented at #ESOC2025: Tirofiban, an IV antiplatelet, given as an adjunct to IVT, improved the odds of excellent functional outcome in patients with AIS, at the cost of an increased risk of intracranial bleeding in the ASSET-IT trial #VoiceOfStroke

Wonderful presentations at #ESOC2025 on inflammation and stroke by Gerrit M. Große & pol camps Renom #athero #stroke European Stroke Org

Nice to see Louise Maes’ work on CTA high risk features of carotid plaque from CONVINCE Stroke Clinical Trials Network Ireland (SCTNI) European Stroke Org #VoiceofStroke #CONVINCE

This systematic review and meta-analysis found a high residual risk of recurrent stroke in patients with atrial fibrillation despite anticoagulation. ja.ma/45meL8C Prof. Ronan Collins

Do sex differences modify the association between CRP, IL-6 and recurrent MACE after stroke 🧠? It doesn’t look like it. Delighted to present this work at European Stroke Org Mater Stroke Stroke Clinical Trials Network Ireland (SCTNI) #VoiceofStroke

Some nice work led by Pádraig Synnott on adherence to blood pressure management guidelines in #CONVINCE Stroke Clinical Trials Network Ireland (SCTNI) Mater Stroke UCD Medicine European Stroke Org #VoiceofStroke #overcomingtherapeuticinertia ❤️🧠

🚨 Reshaping stroke care in Africa: The PINGS-II trial in Ghana shows a simple phone-based nurse-led program can boost blood pressure control from 43% to 67%! Scalable, affordable, and impactful. #Stroke #GlobalHealth #ESOC2025

Research led by Dr John McCabe & Prof Peter Kelly UCD Medicine explores the residual risk of recurrent stroke in patients with atrial fibrillation and suggests that new treatments to prevent stroke in high-risk patients are urgently required.👇 ➡️ucd.ie/research/news/…

#ESOC2025 ☎️#PINGS2 trial for ambulatory BP management using basic phones, nurse-led strategy in Ghana 🇬🇭 ✅1ry out BP<140/90 at 12m: 👉67 vs 43% p0,001

Dr Jane Buckley giving a fascinating overview of her PhD work demonstrating the association between TNFa and recurrent MACE. 👏👏👏John McCabe Stroke Clinical Trials Network Ireland (SCTNI) University College Dublin Mater Stroke European Stroke Org

On Wednesdays we wear pink 🩷 🧠💉

The Irish 🇮🇪Contingent at #ESOC2025 💚Royal College of Physicians of Ireland European Stroke Org #VoiceofStroke

Stratified by on-treatment CRP level in the CONVINCE trial, those with CRP level <2mg/L on colchicine had ~40% reduced risk of recurrent MACE. Lower is better: in a secondary analysis, patients who achieved a CRP level <2mg/L on colchicine treatment had a reduced risk of MACE.

Important data from CONVINCE: lowering CRP with colchicine was associated with a 40% reduction in MACE vs usual care. Lowering inflammation is better. Time for CONVINCE-2?#stroke #ESOC2025 #inflammation European Stroke Org

Stroke unit care saves lives and reduces disability ...1 in 3 acute stroke patients do not get stroke unit care in Ireland - we identified the beds needed in the National Stroke Strategy .. .v little progress unfortunately rte.ie/news/health/20…

Assessing the proportional hazards assumption with 🐈🐈‍⬛ 😸and 🐕🐕‍🦺🐶- check out this months Stats, STAT!

New study reveals rising stroke incidence in young adults since 2015. Regional strategies are crucial due to varying risk factors. #AHAJournals ahajrnls.org/3FdxJnt

Better cardiovascular health lowers autoimmune disease risk—even in genetically susceptible individuals. #AHAJournals ahajrnls.org/4mCyUxg

New Study Published in Neurology Journal: After mild #stroke, more sleep or time spent trying to #sleep tied to thinking problems. hubs.la/Q03pBPK90 #AANscience

Deadline today! This is your last chance to apply for the ESO Edinburgh Stroke Research Workshop, 1–3 September 2025. A 3-day workshop focused on developing a research question for a PhD or MD project.👉 Apply now: ow.ly/2Llb50Voflt #stroke #strokeresearch #strokescience